Table 3 Overall deaths/breast cancer deaths, crude and adjusted comparing BCT to MTX

 BCT

1

1

1

1

 MTX

1.91 (1.56–2.33)

2.33 (1.75–3.10)

1.43 (1.16–1.77)

1.39 (1.02–1.89)

 First screening

1

1

1

1

 Second or later

0.96 (0.74–1.24)

0.88 (0.60–1.30)

0.91 (0.69–1.18)

0.90 (0.61–1.36)

 Interval cancer

1.65 (1.25–2.18)

2.39 (1.62–3.52)

1.12 (0.83–1.50)

1.32 (0.87–2.00)

 1998–2004

1

1

1

1

 2005–2009

0.58 (0.45–0.75)

0.49 (0.34–0.71)

0.59 (0.45–0.76)

0.48 (0.33–0.70)

 50–53

1

1

1

1

 54–57

1.65 (1.13–2.41)

1.60 (1.00–2.59)

1.69 (1.15–2.49)

1.62 (0.99–2.64)

 58–61

1.80 (1.24–2.59)

1.45 (0.90–2.34)

1.95 (1.34–2.84)

1.65 (1.01–2.69)

 62–65

1.94 (1.34–2.88)

1.26 (0.77–2.09)

2.18 (1.49–3.18)

1.47 (0.88–2.46)

 66–69

2.29 (1.58–3.32)

1.26 (0.74–2.13)

2.61 (1.78–3.82)

1.59 (0.93–2.72)

 T1 ≤ 2 cm

1

1

1

1

 T2 > 2–5 ≤ cm

2.27 (1.83–2.81)

3.86 (2.90–5.15)

1.52 (1.22–1.97)

2.08 (1.51–2.86)

 Negative node

1

1

1

1

 1 positive node

1.45 (1.10–1.90)

2.09 (1.46–2.99)

1.32 (1.00–1.74)

1.65 (1.15–2.38)

 2 positive nodes

1.70 (1.14–2.52)

2.48 (1.49–4.12)

1.33 (0.89–1.99)

1.55 (0.92–2.62)

 3 positive nodes

2.39 (1.49–3.85)

3.68 (2.03–6.66)

1.67 (1.02–2.72)

1.96 (1.06–3.63)

 Ductal carcinoma

1

1

1

1

 Lobular carcinoma

0.77 (0.53–1.13)

0.73 (0.42–1.26)

0.77 (0.52–1.14)

0.85 (0.48–1.49)

 Other carcinoma

0.96 (0.68–1.36)

0.89 (0.53–1.49)

0.96 (0.67–1.36)

0.83 (0.49–1.40)

 Grade1

1

1

1

1

 Grade2

1.57 (1.21–2.03)

2.48 (1.57–3.91)

1.34 (1.02–1.76)

1.83 (1.15–2.92)

 Grade3

3.05 (2.31–4.04)

7.58 (4.81–11.93)

1.66 (1.19–2.31)

2.91 (1.73–4.88)

 Unknown grade

1.17 (0.51–2.69)

4.64 (no value)

0.84 (0.36–1.96)

Missing

 Positive

1

1

1

1

 Intermediate

1.66 (1.05–2.61)

3.61 (2.17–6.03)

1.41 (0.89–2.24)

2.48 (1.47–4.20)

 Negative

2.83 (2.24–3.58)

5.01 (3.68–6.82)

1.98 (1.50–2.62)

2.61 (1.80–3.79)